Professor Paul Lee, founder of MSK Doctors (+44 0330 001 0048), has published a new report, "Arthrosamid: The Science Behind a Groundbreaking Knee Osteoarthritis Treatment", detailing the long-lasting efficacy of this innovative hydrogel injection for knee osteoarthritis (OA) pain relief.
-- The recent report examines the treatment’s science, clinical efficacy, and unique advantages compared to traditional therapies like hyaluronic acid (HA).
The full report is available at https://mskdoctors.com/treatments/arthrosamid
Arthrosamid, a non-degradable hydrogel treatment, has demonstrated numerically superior results compared to HA: it cushions and lubricates the knee joint while integrating into the synovial tissue to form a lasting scaffold. As a single-injection treatment, Arthrosamid can relieve pain, reduce stiffness, and improve physical function for two to three years, whereas HA requires injections every six to 18 months, MSK Doctors says.
In his report, Lee presents clinical studies demonstrating lasting symptom improvements and reported reductions in patellofemoral bone marrow lesions as a result of this treatment, highlighting its long-term efficacy and additional benefits.
Lee also presents compelling patient stories illustrating Arthrosamid's life-changing impact. One case features an Olympic athlete who returned to peak performance after receiving the treatment, reporting enhanced mobility and reduced pain during intense training and competition. Another details a leading General Practitioner in Harley Street who experienced a marked improvement in daily activities and quality of life, enabling them to maintain their demanding schedule free from knee pain.
"Chronic knee pain can be debilitating, but Arthrosamid offers a truly revolutionary solution," says Lee. "Clinics like the London Cartilage Clinic, Harley Street and AMSK are providing patients with long-lasting relief thanks to Arthrosamid, which integrates into joint tissue to alleviate pain for up to three years. This is what sets it apart, and why it is transforming the standard of knee osteoarthritis care."
Arthrosamid injections are performed as an outpatient procedure under ultrasound guidance. The treatment involves local anesthesia and intravenous antibiotic cover to ensure patient comfort and safety. Arthrosamid is suitable for individuals with osteoarthritis-related knee pain, joint stiffness, or discomfort unresponsive to traditional treatments. Both the London Cartilage Clinic, Harley Street, and AMSK, offer tailored Arthrosamid treatment plans customised to meet individual patient needs.
With promising patient-reported outcomes and a favourable safety profile, Arthrosamid is rapidly gaining recognition as a groundbreaking intervention for knee osteoarthritis.
A recent patient at MSK Doctors says, “I am extremely satisfied with the results of my Arthrosamid knee injection. I have been pain-free for weeks and have full range of motion. I highly recommend this treatment to anyone suffering from knee pain.”
Learn more by visiting https://mskdoctors.com
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89150061
Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.
